Rogaratinib Completed Phase 2 Trials for Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT04125693Roll-over Study to Continue Treatment With the Investigational Drug Rogaratinib and to Further Test Its Safety